Navigation Links
VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
Date:3/31/2009

ility to obtain necessary FDA approvals; -- our ability to successfully commercialize VIA-2291; -- our ability to obtain and protect our intellectual property related to our product candidates; -- our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche; -- our ability to obtain strategic opportunities to partner and collaborate with large biotechnology or pharmaceutical companies to further develop VIA-2291; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item IA "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008 on file with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and VIA undertakes no obligation to update publicly any of these statements in light of new information or future events.


'/>"/>
SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... directing, via its wholly owned subsidiary, Anelixis Therapeutics ... treatment for ALS that targets the innate immune system. ... Therapy Development Institute received from the 2014 social media ... entire sum of $4 million raised directly by the ...
(Date:5/27/2015)... THOUSAND OAKS, Calif. , May 27, 2015 /PRNewswire/ ... company, has been awarded a U.S. patent for a ... gene in areas such as research, product development and ... useful in regulating key biosynthetic processes that are the ... to offer other seed companies a commercial license to ...
(Date:5/26/2015)... OTTAWA, Canada, and BELLINGHAM, Washington, USA (PRWEB) May 26, ... has signed a formal partnership with the ... Ottawa Centre for Extreme and Quantum Photonics. The center ... in the field of photonics, and will be only ... Arthurs, CEO of SPIE, the international society for ...
(Date:5/26/2015)... HILDEN, Germany , May 26, ... QGEN ; Frankfurt Prime Standard: QIA) today ... Insight ® (QCI™) bioinformatics content and software ... report on genomic variants identified in next-generation sequencing ... bioinformatics platform are in oncology, for somatic and ...
Breaking Biology Technology:Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
... Researchers ... analysis have found that a combination of phenol based , ... array data than either method alone ... of RiboPure RNA Isolation Kits are the first kits that combine , ...
... Dicer and Escherichia coli ... vitro to cleave long dsRNA, producing siRNA cocktails that are , ... endoribonuclease that contains RNase ... enzyme responsible for cleavage of long dsRNAs to siRNA in the , ...
... Mike W. Byrom, Angie M. Cheng and Lance P. Ford* , Ambion, Inc. ... Austin, TX 78744-1832 , *Corresponding ... Abstract Small interfering RNA (siRNA) is an extremely , ... systems, including mammalian cells. Gene specific siRNAs have , ...
Cached Biology Technology:Improve RNA Isolation for Array Analysis and More 2Improve RNA Isolation for Array Analysis and More 3Improve RNA Isolation for Array Analysis and More 4Improve RNA Isolation for Array Analysis and More 5Improve RNA Isolation for Array Analysis and More 6Dicer vs. RNase III for Preparation of siRNA Cocktails 2Dicer vs. RNase III for Preparation of siRNA Cocktails 3Inducing RNAi with siRNA Cocktails Generated by RNase III 2Inducing RNAi with siRNA Cocktails Generated by RNase III 3Inducing RNAi with siRNA Cocktails Generated by RNase III 4Inducing RNAi with siRNA Cocktails Generated by RNase III 5Inducing RNAi with siRNA Cocktails Generated by RNase III 6Inducing RNAi with siRNA Cocktails Generated by RNase III 7Inducing RNAi with siRNA Cocktails Generated by RNase III 8Inducing RNAi with siRNA Cocktails Generated by RNase III 9
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... In a new paper released today in Nature , ... Cech and Leslie Leinwand, detailed a new target for anti-cancer ... DNA. Researchers in the two scientists, laboratories collaborated ... by a drug docked onto the chromosome end at this ...
... The promise of stem cells seems limitless. If they can ... restoring ravaged immune systems, these malleable cells would revolutionize medical ... as scientists seek to better understand the role of these ... Friday, September 14, the Ruth L. and David S. ...
... 21, 2012) - It,s called mile-a-minute weed or "forest ... species that spreads quickly, covering crops, smothering trees and ... State University are spearheading a four-year research project that ... to be vulnerable to rapid environmental change, such as ...
Cached Biology News:CU-Boulder researchers uncover new target for cancer research 2Einstein hosts its first stem cell institute symposium 2Einstein hosts its first stem cell institute symposium 3'Forest killer' plant study explores rapid environmental change factors 2'Forest killer' plant study explores rapid environmental change factors 3
GOAT ANTI SLI...
Protein Phosphorylation...
ANTI L-DOPA...
... Automatic High Sensitivity Laboratory Osmometer for both 0.2 and 2.0 mL samples for ... and record keeping. Bar code reading capability with optional scanner. RS-232 port. ... ... ...
Biology Products: